Cancer Cell
Volume 17, Issue 5, 18 May 2010, Pages 510-522
Journal home page for Cancer Cell

Article
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

https://doi.org/10.1016/j.ccr.2010.03.017Get rights and content
Under an Elsevier user license
open archive

Summary

We have profiled promoter DNA methylation alterations in 272 glioblastoma tumors in the context of The Cancer Genome Atlas (TCGA). We found that a distinct subset of samples displays concerted hypermethylation at a large number of loci, indicating the existence of a glioma-CpG island methylator phenotype (G-CIMP). We validated G-CIMP in a set of non-TCGA glioblastomas and low-grade gliomas. G-CIMP tumors belong to the proneural subgroup, are more prevalent among lower-grade gliomas, display distinct copy-number alterations, and are tightly associated with IDH1 somatic mutations. Patients with G-CIMP tumors are younger at the time of diagnosis and experience significantly improved outcome. These findings identify G-CIMP as a distinct subset of human gliomas on molecular and clinical grounds.

Highlights

► Identification of a CpG island methylator phenotype (G-CIMP) in gliomas ► G-CIMP is tightly associated with IDH1 mutation ► G-CIMP patients are younger at diagnosis and display improved survival ► G-CIMP is more prevalent among low- and intermediate-grade gliomas

CELLCYCLE
DNA
HUMDISEASE

Cited by (0)

13

These authors contributed equally to this work

14

These authors contributed equally to this work